Menu
← Oncology Approval Tracker
FDA DECISION ·
Sorafenib (Nexavar first generic)
sorafenib · Mylan Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic Nexavar for unresectable hepatocellular carcinoma, advanced renal cell carcinoma, or progressive, locally recurrent or metastatic differentiated thyroid carcinoma refractory to radioactive iodine.
LAMPGEN ANALYSIS
Why it matters
Added a generic source of a multi-kinase inhibitor for three established cancer indications.
What research teams should watch
Reconcile labeled indication, dosing and supportive skin care when moving between products.
PRIMARY RECORDS